https://www.marketscreener.com/quote/stock/MODUS-THERAPEUTICS-HOLDIN-125090834/news/Modus-Therapeutics-Updates-on-Sevuparin-Phase-1b-Clinical-Trial-Timelines-40551889/?utm_source=telegram&utm_medium=social&utm_campaign=share